120 related articles for article (PubMed ID: 4055825)
1. Heparinized polyurethanes: in vitro and in vivo studies.
Heyman PW; Cho CS; McRea JC; Olsen DB; Kim SW
J Biomed Mater Res; 1985 Apr; 19(4):419-36. PubMed ID: 4055825
[TBL] [Abstract][Full Text] [Related]
2. Heparin immobilization onto segmented polyurethane-urea surfaces--effect of hydrophilic spacers.
Park KD; Okano T; Nojiri C; Kim SW
J Biomed Mater Res; 1988 Nov; 22(11):977-92. PubMed ID: 3241011
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of blood compatibility of PEO grafted and heparin immobilized polyurethanes.
Han DK; Jeong SY; Kim YH
J Biomed Mater Res; 1989 Aug; 23(A2 Suppl):211-28. PubMed ID: 2674148
[TBL] [Abstract][Full Text] [Related]
4. Chronic performance of polyurethane catheters covalently coated with ATH complex: a rabbit jugular vein model.
Klement P; Du YJ; Berry LR; Tressel P; Chan AK
Biomaterials; 2006 Oct; 27(29):5107-17. PubMed ID: 16781768
[TBL] [Abstract][Full Text] [Related]
5. Antithrombogenic surfaces: characterization and bioactivity of surface immobilized PGE1-heparin conjugate.
Jacobs HA; Okano T; Kim SW
J Biomed Mater Res; 1989 Jun; 23(6):611-30. PubMed ID: 2738078
[TBL] [Abstract][Full Text] [Related]
6. The characteristics of anticoagulation by covalently immobilized heparin.
Miura Y; Aoyagi S; Kusada Y; Miyamoto K
J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
[TBL] [Abstract][Full Text] [Related]
7. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antithrombogenicity of anionic polyurethanes and heparin-bound polyurethanes.
Ito Y; Sisido M; Imanishi Y
J Biomed Mater Res; 1986 Oct; 20(8):1157-77. PubMed ID: 3782177
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer: chronic in vivo studies and clinical application.
Idezuki Y; Watanabe H; Hagiwara M; Kanasugi K; Mori Y
Trans Am Soc Artif Intern Organs; 1975; 21():436-49. PubMed ID: 1146018
[TBL] [Abstract][Full Text] [Related]
10. The dynamics of platelet thrombus formation rate, thrombus retention time, and rate of embolization on a control and heparin bonded polyurethane angio-catheter.
Dewanjee MK; Rowland SM; Kapadvanjwala M; Hellman RL; MacGregor DC; Serafini AN; Palatianos GM; Georgiou MF; Eckstein EC; Sfakianakis GN
ASAIO Trans; 1990; 36(3):M745-9. PubMed ID: 2252801
[TBL] [Abstract][Full Text] [Related]
11. Accurate coagulation studies from heparinized radial artery catheters.
Gregersen RA; Underhill SL; Detter JC; Schmer G; Lax K
Heart Lung; 1987 Nov; 16(6 Pt 1):686-93. PubMed ID: 3679862
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
Cook JJ; Gardell SJ; Holahan MA; Sitko GR; Stump GL; Wallace AA; Gilberto DB; Hare TR; Krueger JA; Dyer DL; Sanderson PE; Vacca JP; Shafer JA; Lynch JJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):503-10. PubMed ID: 10087043
[TBL] [Abstract][Full Text] [Related]
13. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
[TBL] [Abstract][Full Text] [Related]
14. [Thrombogenicity of a new prothrombin complex concentrate].
Klöcking HP; Klessen C; Jablonowski C; Meerbach W; Dornheim G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):645-61. PubMed ID: 6083940
[TBL] [Abstract][Full Text] [Related]
15. Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding.
Esquivel CO; Björck CG; Bergentz SE; Bergqvist D; Larsson R; Carson SN; Dougan P; Nilsson B
Surgery; 1984 Jan; 95(1):102-7. PubMed ID: 6691173
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin.
Zhou Z; Meyerhoff ME
Biomaterials; 2005 Nov; 26(33):6506-17. PubMed ID: 15941584
[TBL] [Abstract][Full Text] [Related]
17. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
Thomas DP; Merton RE; Barrowcliffe TW; Thunberg L; Lindahl U
Thromb Haemost; 1982 Jun; 47(3):244-8. PubMed ID: 7112499
[TBL] [Abstract][Full Text] [Related]
18. Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex.
Du YJ; Brash JL; McClung G; Berry LR; Klement P; Chan AK
J Biomed Mater Res A; 2007 Jan; 80(1):216-25. PubMed ID: 17072855
[TBL] [Abstract][Full Text] [Related]
19. Binding of antithrombin III and thrombin to immobilized heparin under flow conditions.
Byun Y; Jacobs HA; Kim SW
Biotechnol Prog; 1996; 12(2):217-25. PubMed ID: 8857192
[TBL] [Abstract][Full Text] [Related]
20. Minimum discard volume from arterial catheters to obtain coagulation studies free of heparin effect.
Reinhardt AC; Tonneson AS; Bracey A; Goodnough SK
Heart Lung; 1987 Nov; 16(6 Pt 1):699-705. PubMed ID: 3679864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
